The stimulation of phosphofructokinase from human erythrocytes by fructose 2,6-bisphosphate  by Heylen, Alain et al.
Volume 143, number 1 FEBS LETTERS June 1982 
The stimulation of phosphofructokinase from human erythrocytes by 
fructose 2,6-bisphosphate 
Alain Heylen, Emile Van Schaftingen and Henri-GCry Hers 
Laboratoire de Chimie Physiologique, UniversitP Catholique de Louvain and International Institute of Cellular and 
Molecular Pathology, UCL 75.39, 1200 Bruxelles, Belgium 
Received 14 April 1982 
Phosphofructokinase Fructose 2,6_bisphosphate Erythrocytes Glycolysis 
1. INTRODUCTION 
Erythrocytes have an anaerobic life and rely en- 
tirely on glycolysis for their supply of ATP. In 
erythrocytes like in other tissues, the main rate- 
limiting enzyme of glycolysis at physiological pH 
appears to be PFK [ 11. PFK from human erythro- 
cytes has been purified and its properties investi- 
gated [2]. Its general properties are known to be 
similar to those of PFKs from other tissues. 
tained 50 mM Hepes, 5 mM Pi, 0.1 mM AMP, 100 
mM KCl, 0.15 mM NADH, 1 mM NH&l and 
MgC12 in a 5 mM excess over ATP (pH 7.1). Fruc- 
tose 2,6-bisphosphate was prepared as in 141. 
3. RESULTS 
The effect of Fru-2,6-P2 on the saturation curve 
of erythrocyte PFK for its two substrates, Fru-6-P 
and ATP, is shown in lig.lA,B. It appears that 
Because glycolysis in erythrocytes is not known to 
be subjected to the control by hormones or by the 
availability of glucose it was of interest to investi- 
gate if, nevertheless, erythrocyte PFK would be 
sensitive to stimulation by Fru-2,6-P2. 
2. MATERIALS AND METHODS 
PFK was purified from fresh human erythrocytes 
as in [2] up to the first ammonium sulfate precipi- 
tation step (inclusive). Several enzymatic prepara- 
tions, with slightly different specific activities were 
used. Before the assays, the enzyme was filtered on 
Sephadex G-25 equilibrated with 100 mM KF, 15 
mM EGTA, 50 mM Hepes (pH 7.1) 0.1 mM 
Fru-6-P and 0.35 mM Glc-6-P. The preparation was 
virtually free of adenylate kinase and aldolase. PFK 
was assayed as in [3], except that Glc-6-P was 
present at a 3.5-fold greater level than Fru-6-P. 
Unless otherwise indicated, the assay mixture con- 
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Abbreviations: PFK, phosphofructokinase; Hepes, N-2, 
hydroxyethylpiperazine-N’-2-ethanesulfonic acid 
Fig. 1. Effect of Fru-2,6-P2 on (A) the affinity of PFK for 
Fru-6-P and (B) the inhibition of the enzyme by ATP: (A) 
ATP 1.5 mM; (B) Fru-6-P 0.25 mM. The activity 
measured at 5 mM Fru-6-P amounted to 0.084 
pm01 . min -I . mg protein -I in the absence of 
Fru-2,6-P2 and to 0.091 in its presence. 
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Fig.2. Effect of Fru-2,6-P2 on the activity of PFK in the 
presence of various concentrations of Fru-l,6-P2. The 
assays were performed in the presence of0.2 mM Fru-6-P 
and 3 rnk ATP. 
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Fig.3. Effect of Fru- I ,6-P2 on the activity of PFK, in the 
presence of various concentrations of Fru-2,6-P2. The 
assays were performed in the presence of 0.05 mM Pi, 
0.1 mM Fru-6-P and 1.5 mM ATP. 
Fru-2,6-P2, at PM levels increased the affinity for 
Fru-6-P and released the inhibition by ATP. V,,, 
was not affected. The dose-response curve to 
Fru-2,6-P2 is shown in fig.2. Under the experimen- 
tal conditions chosen, a half-maximal effect was 
obtained at close to PM levels of Fru-2,6-P2. The 
same figure shows that 0.5 mM Fru-1,6-P2 had some 
stimulatory action on the enzyme when the acti- 
vity was measured in the absence of Fru-2,6-P2. 
However, in the presence of Fru-2,6-P2, Fru-l,6-P2 
counteracted the positive action of its isomer. 
Glc-l,6-P2 had effects similar to that of Fru- 1,6-P2 
but at 5-fold greater concentrations (not shown). 
The interaction between the two fructose bis- 
phosphates is further illustrated in fig.3. It appears 
again that Fru-1,6-P2 by itself had a slight positive 
effect at 2 lop5 M but that in the presence of 
Fru-2,6-P2 it became inhibitory at 5 x 10 - 5 M. 
The effect of pH on the activity of erythrocytes 
PFK in the absence or in the presence of 1.5 PM 
Fru-2,6-P2 is shown in tig.4. It is apparent that 
Fru-2,6-P2 allowed enzyme activity over pH 
6.6-7.4, at which no activity could be detected in its 
absence. Maximal stimulation was observed at pH 
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Fig.4. Effect of pH on the activity of PFK in the presence 
or in the absence of Fru-2,6-P2. The assays were perform- 
ed in the presence of 0.2 mM Fru-6-P and I .5 mM ATP. 
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Fig.5. Effect of Fru-2,6-P2 on the activity of PFK mea- 
sured at various concentrations of AMP. The assays were 
Performed in the presence of 50 PM Fru-6-P and 1.5 mM 
ATP. 
One can conclude from this work that the pro- 
perty to be stimulated by Fru-2,6-P2 is a general 
property of many PFKs and up to now of all mam- 
malian PFKs. This is despite the fact Fru-2,6-P2 
could not be detected in erythrocytes (unpublished) 
and that glycolysis in erythrocytes is little subjected 
to regulation. 
The synergism between AMP and Fru-2,6-P2, 
which was most striking in the case of liver PFK, is 
illustrated by Iig.5. One can see that in the condi- 
tions chosen, almost no activity could be detected, 
in the presence of AMP ( c 5 mM) or of Fru-2,6-P2 
alone. In contrast, the enzyme became very active in 
the simultaneous presence of small concentrations 
of both stimulators. 
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4. DISCUSSION REFERENCES 
The effects of Fru-2,6-P2 on human erythrocytes 
PFK reported here are very similar to the effect of 
the same effecters on liver and muscle PFKs [3,5]. 
This is particularly apparent for the effect of 
Fru-2,6-P2 to increase the affinity for Fru-6-P and 
to reduce the inhibition by ATP without affecting 
V max and also to be highly synergistic with that of 
AMP. 
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the presence of Fru-2,6-P2. This inhibitory action is 
similar to that observed with yeast PFK (61 and 
suggests that the two fructose bisphosphates have 
affinity for a common site of fixation. The inter- 
relationship between the stimulation by Fru-2,6-P2 
and pH had not been reported although it was for- 
seeable. It is known that H+ is a negative effector of 
PFKs in general and therefore that the effect of 
positive effecters would be the most apparent in the 
acid range of pH. The effect of Fru-2,6-P2 in this 
respect is, therefore, not different from that of other 
positive effecters. 
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